Literature DB >> 29757019

Optical Coherence Tomography Angiography in Glaucoma Care.

Sunee Chansangpetch1,2, Shan C Lin1.   

Abstract

PURPOSE: To provide the reader with information on the principal techniques of optical coherence tomography angiography (OCTA); the current literature on OCTA reproducibility; its applications to glaucoma detection and monitoring of progression; and the role of OCTA in the assessment of the vascular component in glaucoma pathogenesis.
METHODS: A literature review of the pertinent publications for the OCTA in relation to the development, techniques, and its use in glaucoma was carried out.
RESULTS: Rapid improvements in optical coherence tomography (OCT) technology have allowed for enhancement of both image resolution and scanning speed, and the development of vascular assessment modality. OCTA is the non-invasive in vivo imaging of the vasculature located within the retina and optic nerve head area. The principle of OCTA is to use the variations in OCT signals caused by moving particles as the contrast mechanism for imaging of flow. Several algorithms which aim to maximize the contrast signal and minimize the noise have been developed including the phase-based techniques, intensity-based techniques (e.g., split-spectrum amplitude decorrelation angiography (SSADA)), and complex-based techniques (e.g., optical microangiography (OMAG)). With its reliable technique, high image resolution, and current availability, OCTA has been widely used in the assessment of posterior segment diseases including glaucoma in which ocular perfusion dysfunction has been proposed as a pathophysiological mechanism.
CONCLUSION: OCTA may enhance our knowledge of glaucoma pathogenesis and offer an improvement in our ability to detect glaucomatous change.

Entities:  

Keywords:  Glaucoma; glaucoma imaging; ocular perfusion; optical coherence tomography; optical coherence tomography angiography

Mesh:

Year:  2018        PMID: 29757019     DOI: 10.1080/02713683.2018.1475013

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma.

Authors:  Hae Young-Lopilly Park; Da Young Shin; Soo Ji Jeon; Chan Kee Park
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

3.  Optic nerve head microvascular characteristics in patients with unilateral pseudoexfoliation syndrome: an optical coherence tomography angiography study.

Authors:  Ozlem Dikmetas; Sepideh Lotfi Sadigh; Cansev Şekerler; Sibel Kocabeyoğlu; Sevilay Karahan; Ali Bulent Cankaya
Journal:  Int Ophthalmol       Date:  2022-01-30       Impact factor: 2.029

4.  Spatial positional relationship between macular superficial vessel density and ganglion cell-inner plexiform layer thickness in primary angle closure glaucoma.

Authors:  Yongdong Lin; Di Ma; Hongxi Wang; Shirong Chen; Weihao Cai; Anlin Zhang; Mingzhi Zhang
Journal:  Int Ophthalmol       Date:  2021-08-15       Impact factor: 2.031

5.  Evaluation of macular and peripapillary vascular parameter change in healthy subjects after caffeine intake using optical coherence tomography angiography.

Authors:  Busra Yilmaz Tugan; Sevgi Subasi; Dilara Pirhan; Levent Karabas; Nursen Yuksel; Kubra Demirci Kucuk
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 1.848

Review 6.  The characteristics of fundus microvascular alterations in the course of glaucoma: a narrative review.

Authors:  Xintong Fan; Yue Ying; Ruyi Zhai; Qilian Sheng; Yanan Sun; Huan Xu; Xiangmei Kong
Journal:  Ann Transl Med       Date:  2022-05

Review 7.  Optical Coherence Tomography and Glaucoma.

Authors:  Alexi Geevarghese; Gadi Wollstein; Hiroshi Ishikawa; Joel S Schuman
Journal:  Annu Rev Vis Sci       Date:  2021-07-09       Impact factor: 7.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.